-
公开(公告)号:US10284964B2
公开(公告)日:2019-05-07
申请号:US15180719
申请日:2016-06-13
Applicant: EarLens Corporation
Inventor: Jake L. Olsen , David Chazan , Jonathan P. Fay , Micha Rosen , Sunil Puria
Abstract: Embodiments of the present invention provide improved methods and apparatus suitable for use with hearing devices. A vapor deposition process can be used to make a retention structure having a shape profile corresponding to a tissue surface, such as a retention structure having a shape profile corresponding to one or more of an eardrum, the eardrum annulus, or a skin of the ear canal. The retention structure can be resilient and may comprise an anatomically accurate shape profile corresponding to a portion of the ear, such that the resilient retention structure provides mechanical stability for an output transducer assembly placed in the ear for an extended time. The output transducer may couple to the eardrum with direct mechanical coupling or acoustic coupling when retained in the ear canal with the retention structure.
-
公开(公告)号:US10238872B2
公开(公告)日:2019-03-26
申请号:US15264864
申请日:2016-09-14
Applicant: Nalu Medical, Inc.
Inventor: Daniel Pivonka , Anatoly Yakovlev
Abstract: A medical apparatus for a patient includes an external system configured to transmit one or more transmission signals, each transmission signal having at least power or data. An implantable system is configured to receive the one or more transmission signals from the external system, and the external system includes a first external device with at least one external antenna configured to transmit a first transmission signal to the implantable system. The first transmission signal includes at least power or data, and an external transmitter is configured to drive the at least one external antenna. An external power supply is configured to provide power to at least the external transmitter, and an external controller is configured to control the external transmitter. A first implantable device includes at least one implantable antenna configured to receive the first transmission signal from the first external device. An implantable receiver is configured to receive the first transmission signal from the at least one implantable antenna. At least one implantable functional element is configured to interface with the patient. An implantable controller is configured to control the at least one implantable functional element. The medical apparatus is configured to neuromodulate tissue and/or record patient information.
-
公开(公告)号:US10237663B2
公开(公告)日:2019-03-19
申请号:US15706236
申请日:2017-09-15
Applicant: EarLens Corporation
Inventor: Sunil Puria , Micha Rosen , Jonathan P. Fay , Paul Rucker , James Stone
Abstract: A device to transmit an audio signal to a user comprises a transducer and a support. The support is configured for placement on the eardrum to drive the eardrum. The transducer is coupled to the support at a first location to decrease occlusion and a second location to drive the eardrum. The transducer may comprise one or more of an electromagnetic balanced armature transducer, a piezoelectric transducer, a magnetostrictive transducer, a photostrictive transducer, or a coil and magnet. The device may find use with open canal hearing aids.
-
公开(公告)号:US10232170B2
公开(公告)日:2019-03-19
申请号:US15844367
申请日:2017-12-15
Applicant: BIOTRACE MEDICAL, INC.
Inventor: Kurt Sparks , Ellis Garai , Aravind Swaminathan , Laura Dietch , Marcel Sicotte
IPC: A61N1/05 , A61B6/12 , A61B17/22 , A61B5/024 , A61B5/0215 , A61N1/36 , A61B5/042 , A61B5/00 , A61B90/00
Abstract: Electrical sensing/stimulation apparatuses for positioning at least one electrode within body tissue are provided. An electrical sensing/stimulation apparatus may comprise an elongate lead body having at least one internal lumen, at least one sensing/stimulation electrode, a deployable/retractable displacement member that moves or biases at least one electrode towards a prescribed direction by the user, a tissue attachment mechanism for affixing the distal segment of the device to body tissue, and an atraumatic distal lead body termination. In a retracted configuration, the attachment mechanism is positioned substantially within the distal segment of the lead body, and in the deployed configuration, the attachment mechanism extends from the axis of the lead body to engage body tissue.
-
公开(公告)号:US10123801B2
公开(公告)日:2018-11-13
申请号:US15130764
申请日:2016-04-15
Applicant: ZIPLINE MEDICAL, INC.
Inventor: Amir Belson , Eric Storne , Jeremy Edinger , Zachary Kimura , Alan Schaer , Keiichiro Ichiryu
Abstract: A wound dressing for use with a closure device is disclosed. The first and second base panels of the closure device are positioned on opposite lateral sides of a wound or incision. The base panels are coupled together to maintain wound or incision closure. A release liner is removed from a bottom surface of the wound dressing. The wound dressing is positioned over the closure device and the wound or incision. Exudate is absorbed by an absorbent material of the wound dressing through a porous strip of the wound dressing. The wound dressing is slightly larger than the closure device so that its perimeter area is adhered to the skin area around the closure device. Alternatively or in combination, the wound dressing is lightly adhered to the closure device and wound or incision area so that it can be removed without harming the underlying device and tissues.
-
公开(公告)号:US10028785B2
公开(公告)日:2018-07-24
申请号:US14616312
申请日:2015-02-06
Applicant: Acublate, Inc.
Inventor: Bob Sueh-Chien Hu , Girish Ananth Narayan , Byongho Park
Abstract: An ablation catheter comprises an elongate catheter body and a branch electrode element. The elongate catheter body has a central axis, a distal end, and a proximal end. The elongate catheter body is configured to be steered within a heart chamber. The branch electrode element has a base end and a working end or tip. The base end is secured to the elongate catheter body at a location spaced proximally of the distal end and an effector on the working end. The branch electrode element is configured to evert when the distal end of the elongate catheter body is in a pulmonary vein ostium or os so that the effector can be selectively engaged against locations surrounding the pulmonary vein os which differ in radial direction and distance. One or more of linear or curved ablation patterns are generated on tissue adjacent the pulmonary vein os with the effector.
-
公开(公告)号:US10010710B2
公开(公告)日:2018-07-03
申请号:US14958803
申请日:2015-12-03
Applicant: ZipLine Medical, Inc.
Inventor: Amir Belson , Brian Beckey , James J. Leary
IPC: A61B17/08 , A61M39/02 , A61M5/32 , A61M5/28 , A61M5/142 , A61N1/32 , A61M5/24 , A61M25/06 , A61M39/04 , A61M5/158 , A61M25/00 , A61M37/00 , A61F13/00 , A61B17/00 , A61B17/32
CPC classification number: A61M39/02 , A61B17/08 , A61B17/085 , A61B2017/00889 , A61B2017/00893 , A61B2017/081 , A61B2017/086 , A61B2017/088 , A61B2017/320052 , A61F2013/0017 , A61M5/142 , A61M5/14248 , A61M5/2425 , A61M5/28 , A61M5/3298 , A61M25/065 , A61M39/04 , A61M2005/1581 , A61M2005/1586 , A61M2025/0057 , A61M2037/0007 , A61M2039/0205 , A61M2202/0478 , A61N1/326 , A61N1/327
Abstract: A surgical or wound closure device utilizes a slide fastener for rapidly closing a surgical incision or wound with precise apposition of the sides of the incision. The surgical closure devices are configured for linear incisions, shaped incisions, such as used for wedge biopsy or excisional biopsy, and long incisions, such as used for laparotomy or surgical removal of redundant skin. The surgical closure device may be adhered to the patient's skin prior to making an incision and is subsequently used for closing the incision.
-
公开(公告)号:US10003877B2
公开(公告)日:2018-06-19
申请号:US15368487
申请日:2016-12-02
Applicant: EarLens Corporation
Inventor: Rodney C. Perkins , William M. Facteau , Sunil Puria
CPC classification number: H04R1/1016 , G02B27/017 , G02B2027/0178 , G02C11/06 , G02C11/10 , H04R1/028 , H04R23/008 , H04R2420/07 , H04R2460/09 , H04R2460/13
Abstract: Contact hearing devices for use with a wearable communication apparatus are disclosed to provide the user with an open ear canal to hear ambient sound and sound from an audio signal. The disclosed devices and systems have an advantage of providing sound to user from the audio signal, in many embodiments without creating sound that can be perceived by others. The contact hearing device can also be used to amplify ambient sound to provide a hearing assistance to users with diminished hearing. The wearable information apparatus can be configured to couple wirelessly to the contact transducer assembly, such that the wearable information apparatus can be removed while the contact transducer assembly remains placed on the user.
-
公开(公告)号:US09987080B2
公开(公告)日:2018-06-05
申请号:US15720199
申请日:2017-09-29
Applicant: Gynesonics, Inc.
Inventor: Jessica Grossman
CPC classification number: A61B18/1477 , A61B2018/00559 , A61B2018/143 , A61B2090/378 , A61B2090/3782
Abstract: Methods and devices for both imaging and treating uterine fibroid tumors in one real-time system are provided. One minimally invasive method comprises introducing a sheath into a uterus and determining a location of a fibroid using a visualization element within or on the sheath. Upon identification, a portion of the sheath is steered to position at least one treatment needle at the determined location. The needle is then anchored in uterine tissue and the fibroid treated with the needle.
-
公开(公告)号:US11026998B2
公开(公告)日:2021-06-08
申请号:US16229711
申请日:2018-12-21
Applicant: Rani Therapeutics, LLC
Inventor: Mercedes Morales , Mir A. Imran , Radhika Korupolu , Mir Hashim
Abstract: Embodiments of the invention provide shaped masses comprising one or more drugs such as proteins or polypeptides and methods for forming such shaped masses. One embodiment provides a shaped mass comprising a drug such as a protein or polypeptide having a biological activity in the body of a mammal. The shaped mass is formed by compression of a precursor material comprising the drug wherein an amount of biologically active drug in the mass is a preserved above a minimum level. Drugs which may be incorporated into the shaped mass may include one or more glucose regulating proteins such as insulin, incretins; and immunoglobulins such as TNF-inhibiting antibodies or interleukin neutralizing antibodies. Embodiments of the shaped mass may be incorporated into a tissue penetrating member which is inserted into the intestinal wall allowing for the oral delivery of proteins and peptides which would otherwise be degraded in the intestinal tract.
-
-
-
-
-
-
-
-
-